首页 > 最新文献

Iranian Journal of Microbiology最新文献

英文 中文
Immunomodulatory effects of live and UV-killed Bacillus subtilis natto on inflammatory response in human colorectal adenocarcinoma cell line in vitro. 活的和紫外线杀灭的纳豆枯草芽孢杆菌对体外人类结直肠腺癌细胞系炎症反应的免疫调节作用
IF 1.3 Q4 MICROBIOLOGY Pub Date : 2024-08-01 DOI: 10.18502/ijm.v16i4.16301
Parisa Abedi Elkhichi, Masoumeh Aslanimehr, Amir Javadi, Abbas Yadegar

Background and objectives: Colorectal cancer (CRC) is a heterogeneous disease of the colon or rectum arising from adenoma precursors and serrated polyps. Recently, probiotics have been proposed as an effective and potential therapeutic approach for CRC prevention and treatment. Probiotics have been shown to alleviate inflammation by restoring the integrity of the mucosal barrier and impeding cancer progression.

Materials and methods: In this study, we aimed to investigate the immunomodulatory effects of live and UV-killed Bacillus subtilis natto on the inflammatory response in CRC. Caco-2 cells were exposed to various concentrations of live and UV- killed B. subtilis natto, and cell viability was assessed using MTT assay. Gene expression analysis of IL-10, TGF-β, TLR2 and TLR4 was performed using RT-qPCR.

Results: Our findings showed that both live and UV-killed B. subtilis natto caused significant reduction in inflammatory response by decreasing the gene expression of TLR2 and TLR4, and enhancing the gene expression of IL-10 and TGF-β in Caco-2 cells as compared to control group.

Conclusion: The results of this study suggest that live and UV-killed B. subtilis natto may hold potential as a therapeutic supplement for modulating inflammation in CRC.

背景和目的:结肠直肠癌(CRC)是结肠或直肠的一种异质性疾病,由腺瘤前体和锯齿状息肉引起。最近,有人提出益生菌是预防和治疗 CRC 的一种有效和潜在的治疗方法。研究表明,益生菌可通过恢复粘膜屏障的完整性来缓解炎症,并阻碍癌症进展:本研究旨在探讨纳豆枯草芽孢杆菌活菌和紫外线杀灭菌对 CRC 炎症反应的免疫调节作用。将 Caco-2 细胞暴露于不同浓度的纳豆活菌和紫外线杀灭的枯草芽孢杆菌,用 MTT 法评估细胞活力。使用 RT-qPCR 对 IL-10、TGF-β、TLR2 和 TLR4 进行基因表达分析:结果:我们的研究结果表明,与对照组相比,活纳豆菌和紫外线杀灭纳豆菌都能降低 TLR2 和 TLR4 的基因表达,提高 IL-10 和 TGF-β 的基因表达,从而显著降低 Caco-2 细胞的炎症反应:本研究结果表明,活体和紫外线杀灭的枯草芽孢杆菌纳豆有可能成为调节 CRC 炎症反应的治疗补充剂。
{"title":"Immunomodulatory effects of live and UV-killed <i>Bacillus subtilis</i> natto on inflammatory response in human colorectal adenocarcinoma cell line <i>in vitro</i>.","authors":"Parisa Abedi Elkhichi, Masoumeh Aslanimehr, Amir Javadi, Abbas Yadegar","doi":"10.18502/ijm.v16i4.16301","DOIUrl":"https://doi.org/10.18502/ijm.v16i4.16301","url":null,"abstract":"<p><strong>Background and objectives: </strong>Colorectal cancer (CRC) is a heterogeneous disease of the colon or rectum arising from adenoma precursors and serrated polyps. Recently, probiotics have been proposed as an effective and potential therapeutic approach for CRC prevention and treatment. Probiotics have been shown to alleviate inflammation by restoring the integrity of the mucosal barrier and impeding cancer progression.</p><p><strong>Materials and methods: </strong>In this study, we aimed to investigate the immunomodulatory effects of live and UV-killed <i>Bacillus subtilis</i> natto on the inflammatory response in CRC. Caco-2 cells were exposed to various concentrations of live and UV- killed <i>B. subtilis</i> natto, and cell viability was assessed using MTT assay. Gene expression analysis of IL-10, TGF-β, TLR2 and TLR4 was performed using RT-qPCR.</p><p><strong>Results: </strong>Our findings showed that both live and UV-killed <i>B. subtilis</i> natto caused significant reduction in inflammatory response by decreasing the gene expression of TLR2 and TLR4, and enhancing the gene expression of IL-10 and TGF-β in Caco-2 cells as compared to control group.</p><p><strong>Conclusion: </strong>The results of this study suggest that live and UV-killed <i>B. subtilis</i> natto may hold potential as a therapeutic supplement for modulating inflammation in CRC.</p>","PeriodicalId":14633,"journal":{"name":"Iranian Journal of Microbiology","volume":"16 4","pages":"434-442"},"PeriodicalIF":1.3,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11389770/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142287448","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Precision medicine in practice: unravelling the prevalence and antibiograms of urine cultures for informed decision making in federal tertiary care- a guide to empirical antibiotics therapy. 实践中的精准医疗:揭示尿培养的流行率和抗生素图谱,为联邦三级医疗机构的知情决策提供依据--经验性抗生素治疗指南。
IF 1.3 Q4 MICROBIOLOGY Pub Date : 2024-08-01 DOI: 10.18502/ijm.v16i4.16306
Umme Farwa, Samia Wazir, Farhan Kursheed, Bisma Shoaib, Sheza Batool, Muhammad Shafiq

Background and objectives: Urinary tract infections (UTIs), one of the most prevalent bacterial infections, are facing limited treatment options due to escalating concern of antibiotic resistance. Urine cultures significantly help in identification of etiological agents responsible for these infections. Assessment of antibiotic susceptibility patterns of these bacteria aids in tackling the emerging concern of antibiotic resistance and establishment of empirical therapy guidelines. Our aim was to determine various agents responsible for urinary tract infections and to assess their antibiotic susceptibility patterns.

Materials and methods: This cross-sectional study was performed over a period of six months from January 2023 to July 2023 in Department of Microbiology of Pakistan Institute of Medical Sciences (PIMS).

Results: Out of 2957 positive samples, Gram negative bacteria were the most prevalent in 1939 (65.6%) samples followed by Gram positive bacteria in 418 (14.1%) and Candida spp. in 269 (9.1%) samples. In gram negative bacteria, Escherichia coli (E. coli) was the most prevalent bacteria isolated from 1070 samples (55.2%) followed by Klebsiella pneumoniae in 397 samples (20.5%). In Gram positive bacteria, Enterococcus spp. was the most common bacteria in 213 samples (51%) followed by Staphylococcus aureus in 120 samples (28.7%). Amikacin was the most sensitive drug (91%) for Gram negative bacteria. Gram positive bacteria were most susceptible to linezolid (97%-100%).

Conclusion: The generation of a hospital tailored antibiogram is essential for the effective management of infections and countering antibiotic resistance. By adopting antimicrobial stewardship strategies by deeper understanding of sensitivity patterns, we can effectively combat antibiotic resistance.

背景和目的:尿路感染(UTI)是最常见的细菌感染之一,但由于抗生素耐药性问题日益严重,治疗方案十分有限。尿液培养有助于确定导致这些感染的病原体。对这些细菌的抗生素敏感性模式进行评估有助于解决新出现的抗生素耐药性问题和制定经验性治疗指南。我们的目的是确定导致尿路感染的各种病原体,并评估它们的抗生素敏感性模式:这项横断面研究于 2023 年 1 月至 2023 年 7 月在巴基斯坦医学科学研究所(PIMS)微生物学系进行,为期 6 个月:在 2957 份阳性样本中,革兰氏阴性菌最多,占 1939 份样本(65.6%),其次是革兰氏阳性菌 418 份样本(14.1%)和念珠菌 269 份样本(9.1%)。在革兰氏阴性细菌中,从 1070 个样本(55.2%)中分离出的大肠埃希菌(E. coli)是最普遍的细菌,其次是 397 个样本(20.5%)中的肺炎克雷伯氏菌(Klebsiella pneumoniae)。在革兰氏阳性细菌中,213 个样本(51%)中最常见的是肠球菌属,其次是 120 个样本(28.7%)中的金黄色葡萄球菌。阿米卡星是对革兰氏阴性菌最敏感的药物(91%)。革兰氏阳性菌对利奈唑胺最敏感(97%-100%):编制医院定制的抗生素图谱对于有效控制感染和应对抗生素耐药性至关重要。通过深入了解敏感性模式,采取抗菌药物管理策略,我们可以有效地对抗抗生素耐药性。
{"title":"Precision medicine in practice: unravelling the prevalence and antibiograms of urine cultures for informed decision making in federal tertiary care- a guide to empirical antibiotics therapy.","authors":"Umme Farwa, Samia Wazir, Farhan Kursheed, Bisma Shoaib, Sheza Batool, Muhammad Shafiq","doi":"10.18502/ijm.v16i4.16306","DOIUrl":"https://doi.org/10.18502/ijm.v16i4.16306","url":null,"abstract":"<p><strong>Background and objectives: </strong>Urinary tract infections (UTIs), one of the most prevalent bacterial infections, are facing limited treatment options due to escalating concern of antibiotic resistance. Urine cultures significantly help in identification of etiological agents responsible for these infections. Assessment of antibiotic susceptibility patterns of these bacteria aids in tackling the emerging concern of antibiotic resistance and establishment of empirical therapy guidelines. Our aim was to determine various agents responsible for urinary tract infections and to assess their antibiotic susceptibility patterns.</p><p><strong>Materials and methods: </strong>This cross-sectional study was performed over a period of six months from January 2023 to July 2023 in Department of Microbiology of Pakistan Institute of Medical Sciences (PIMS).</p><p><strong>Results: </strong>Out of 2957 positive samples, Gram negative bacteria were the most prevalent in 1939 (65.6%) samples followed by Gram positive bacteria in 418 (14.1%) and <i>Candida</i> spp. in 269 (9.1%) samples. In gram negative bacteria, <i>Escherichia coli (E. coli)</i> was the most prevalent bacteria isolated from 1070 samples (55.2%) followed by <i>Klebsiella pneumoniae</i> in 397 samples (20.5%). In Gram positive bacteria, <i>Enterococcus</i> spp. was the most common bacteria in 213 samples (51%) followed by <i>Staphylococcus aureus</i> in 120 samples (28.7%). Amikacin was the most sensitive drug (91%) for Gram negative bacteria. Gram positive bacteria were most susceptible to linezolid (97%-100%).</p><p><strong>Conclusion: </strong>The generation of a hospital tailored antibiogram is essential for the effective management of infections and countering antibiotic resistance. By adopting antimicrobial stewardship strategies by deeper understanding of sensitivity patterns, we can effectively combat antibiotic resistance.</p>","PeriodicalId":14633,"journal":{"name":"Iranian Journal of Microbiology","volume":"16 4","pages":"477-483"},"PeriodicalIF":1.3,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11389760/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142287473","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Recombinant outer membrane protein Lipl41 from Leptospira interrogans robust immune responses in mice model. 审讯钩端螺旋体的重组外膜蛋白 Lipl41 在小鼠模型中产生了强有力的免疫反应。
IF 1.3 Q4 MICROBIOLOGY Pub Date : 2024-08-01 DOI: 10.18502/ijm.v16i4.16314
Narges Golab, Pejvak Khaki, Majid Tebianian, Majid Esmaelizad, Naser Harzandi

Background and objectives: Leptospirosis is an infectious zoonotic disease that can result in severe complications. It is widespread, especially in hot and humid climates such as the northern region of Iran. The immune responses to leptospirosis are multifaceted. Lipl41 is an outer membrane protein that is expressed during infection and is highly conserved among pathogenic species. This makes it a good candidate for diagnosis and induction of specific immune responses. The aim of the present study was to evaluate immune responses against recombinant Lipl41 in mice.

Materials and methods: After immunizing of different groups of mice with recombinant Lipl41 (rLipl41), the levels of specific antibodies and cytokine profiles interferon-gamma/interleukin-4 (IFN-γ/IL-4) were measured.

Results: The results revealed that rLipl41 showed a significant increase in antibody levels compared with the control groups (P< 0.05). Although the level of IL-4 in the groups that received Lipl41 was similar to that in the other control groups, the IFN-γ levels showed a significant increase (P<0.05).

Conclusion: It has been concluded that recombinant Lipl41 protein could strongly stimulate specific immune responses and be considered a potential candidate for vaccine development and diagnostic research.

背景和目的:钩端螺旋体病是一种可导致严重并发症的人畜共患传染病。它广泛流行,尤其是在伊朗北部地区等炎热潮湿的气候条件下。钩端螺旋体病的免疫反应是多方面的。Lipl41 是一种在感染期间表达的外膜蛋白,在致病物种之间高度保守。这使其成为诊断和诱导特异性免疫反应的良好候选蛋白。本研究旨在评估小鼠对重组 Lipl41 的免疫反应:用重组 Lipl41(rLipl41)免疫不同组别的小鼠后,测定特异性抗体和细胞因子γ干扰素/白细胞介素-4(IFN-γ/IL-4)的水平:结果:结果显示,与对照组相比,rLipl41 的抗体水平显著增加(P< 0.05)。虽然接受 Lipl41 治疗组的 IL-4 水平与其他对照组相近,但 IFN-γ 水平却显著增加(PC结论:Lipl41 重组人免疫球蛋白可显著提高抗体水平:结论:重组 Lipl41 蛋白能强烈刺激特异性免疫反应,可作为疫苗开发和诊断研究的潜在候选物质。
{"title":"Recombinant outer membrane protein Lipl41 from <i>Leptospira interrogans</i> robust immune responses in mice model.","authors":"Narges Golab, Pejvak Khaki, Majid Tebianian, Majid Esmaelizad, Naser Harzandi","doi":"10.18502/ijm.v16i4.16314","DOIUrl":"https://doi.org/10.18502/ijm.v16i4.16314","url":null,"abstract":"<p><strong>Background and objectives: </strong>Leptospirosis is an infectious zoonotic disease that can result in severe complications. It is widespread, especially in hot and humid climates such as the northern region of Iran. The immune responses to leptospirosis are multifaceted. Lipl41 is an outer membrane protein that is expressed during infection and is highly conserved among pathogenic species. This makes it a good candidate for diagnosis and induction of specific immune responses. The aim of the present study was to evaluate immune responses against recombinant Lipl41 in mice.</p><p><strong>Materials and methods: </strong>After immunizing of different groups of mice with recombinant Lipl41 (rLipl41), the levels of specific antibodies and cytokine profiles interferon-gamma/interleukin-4 (IFN-γ/IL-4) were measured.</p><p><strong>Results: </strong>The results revealed that rLipl41 showed a significant increase in antibody levels compared with the control groups (P< 0.05). Although the level of IL-4 in the groups that received Lipl41 was similar to that in the other control groups, the IFN-γ levels showed a significant increase (P<0.05).</p><p><strong>Conclusion: </strong>It has been concluded that recombinant Lipl41 protein could strongly stimulate specific immune responses and be considered a potential candidate for vaccine development and diagnostic research.</p>","PeriodicalId":14633,"journal":{"name":"Iranian Journal of Microbiology","volume":"16 4","pages":"545-551"},"PeriodicalIF":1.3,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11389765/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142287475","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Sequence analysis of isolated strains of herpes zoster virus among patients with shingles. 带状疱疹患者中分离出的带状疱疹病毒株的序列分析。
IF 1.3 Q4 MICROBIOLOGY Pub Date : 2024-08-01 DOI: 10.18502/ijm.v16i4.16312
Mohammed Jasim Mohammed Shallal, Hind Ali Nasser, Alaa Abdul Hassen Naif

Background and objectives: Herpes zoster, or shingles, is caused by the varicella-zoster virus (VZV), which initially presents as chickenpox in children. VZV is a global health concern, especially in winter and spring, affecting 10-20% of adults over 50 and posing a 30% risk for the general population. This study used PCR to detect VZV, confirming results with duplicated DNA samples and identifying 234 bp fragments by targeting the gpB gene.

Materials and methods: This study examined 50 herpes zoster cases from October 2020 to April 2021, involving 30 males and 20 females aged 10 to 90, diagnosed by dermatologists. Data were collected via a questionnaire. PCR detected VZV by amplifying the gpB and MCP genes from skin lesion samples. Six positive 234-bp PCR products were sequenced at Macrogen Inc. in Seoul, South Korea.

Results: Six DNA samples with 234 bp amplicons were sequenced, showing 99-100% similarity to human alpha herpesvirus sequences in the gpB gene. NCBI BLAST matched these sequences to a reference (GenBank acc. MT370830.1), assigning accession numbers LC642111, LC642112, and LC642113. Eight nucleic acid substitutions caused amino acid changes in the gpB protein: isoleucine to threonine, serine to isoleucine, and threonine to Proline. These variants were deposited in NCBI GenBank as gpB3 samples.

Conclusion: The study found high sequence similarity to known VZV sequences, identifying six nucleic acid variations and eight SNPs. Notable amino acid changes in the gpB protein were deposited in NCBI GenBank as the gpB3 sample.

背景和目的:带状疱疹是由水痘-带状疱疹病毒(VZV)引起的,最初在儿童中表现为水痘。VZV 是全球关注的健康问题,尤其是在冬季和春季,影响 10-20% 的 50 岁以上成年人,对普通人群造成 30% 的风险。本研究使用 PCR 检测 VZV,用重复的 DNA 样本确认结果,并通过靶向 gpB 基因鉴定 234 bp 片段:本研究调查了 2020 年 10 月至 2021 年 4 月期间由皮肤科医生诊断的 50 例带状疱疹病例,包括 30 名男性和 20 名女性,年龄在 10 至 90 岁之间。数据通过问卷调查收集。PCR 通过扩增皮损样本中的 gpB 和 MCP 基因检测 VZV。韩国首尔 Macrogen 公司对 6 个 234 bp PCR 阳性产物进行了测序:结果:对六个 234 bp 扩增子的 DNA 样品进行了测序,结果显示其 gpB 基因与人类阿尔法疱疹病毒序列的相似度为 99%-100%。NCBI BLAST将这些序列与参考文献(GenBank acc.8 个核酸置换导致 gpB 蛋白的氨基酸发生变化:异亮氨酸变苏氨酸、丝氨酸变异亮氨酸、苏氨酸变脯氨酸。这些变体作为 gpB3 样本存入 NCBI GenBank:该研究发现,gpB3 的序列与已知的 VZV 序列高度相似,确定了 6 个核酸变异和 8 个 SNP。gpB 蛋白中显著的氨基酸变化被作为 gpB3 样本存入 NCBI GenBank。
{"title":"Sequence analysis of isolated strains of herpes zoster virus among patients with shingles.","authors":"Mohammed Jasim Mohammed Shallal, Hind Ali Nasser, Alaa Abdul Hassen Naif","doi":"10.18502/ijm.v16i4.16312","DOIUrl":"https://doi.org/10.18502/ijm.v16i4.16312","url":null,"abstract":"<p><strong>Background and objectives: </strong>Herpes zoster, or shingles, is caused by the varicella-zoster virus (VZV), which initially presents as chickenpox in children. VZV is a global health concern, especially in winter and spring, affecting 10-20% of adults over 50 and posing a 30% risk for the general population. This study used PCR to detect VZV, confirming results with duplicated DNA samples and identifying 234 bp fragments by targeting the gpB gene.</p><p><strong>Materials and methods: </strong>This study examined 50 herpes zoster cases from October 2020 to April 2021, involving 30 males and 20 females aged 10 to 90, diagnosed by dermatologists. Data were collected via a questionnaire. PCR detected VZV by amplifying the gpB and MCP genes from skin lesion samples. Six positive 234-bp PCR products were sequenced at Macrogen Inc. in Seoul, South Korea.</p><p><strong>Results: </strong>Six DNA samples with 234 bp amplicons were sequenced, showing 99-100% similarity to human alpha herpesvirus sequences in the gpB gene. NCBI BLAST matched these sequences to a reference (GenBank acc. MT370830.1), assigning accession numbers LC642111, LC642112, and LC642113. Eight nucleic acid substitutions caused amino acid changes in the gpB protein: isoleucine to threonine, serine to isoleucine, and threonine to Proline. These variants were deposited in NCBI GenBank as gpB3 samples.</p><p><strong>Conclusion: </strong>The study found high sequence similarity to known VZV sequences, identifying six nucleic acid variations and eight SNPs. Notable amino acid changes in the gpB protein were deposited in NCBI GenBank as the gpB3 sample.</p>","PeriodicalId":14633,"journal":{"name":"Iranian Journal of Microbiology","volume":"16 4","pages":"524-535"},"PeriodicalIF":1.3,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11389764/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142287476","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Antibiotyping, RAPD- and ERIC-PCR fingerprinting of Klebsiella pneumoniae clinical isolates at a tertiary reference hospital in Denpasar, Bali, Indonesia. 印度尼西亚巴厘岛登巴萨一家三级参考医院对肺炎克雷伯氏菌临床分离物进行抗生素鉴定、RAPD 和 ERIC-PCR 指纹图谱分析。
IF 1.3 Q4 MICROBIOLOGY Pub Date : 2024-06-01 DOI: 10.18502/ijm.v16i3.15761
Ni Nengah Dwi Fatmawati, Felicia Aviana, Ronny Maharianto, Gede Ngurah Rsi Suwardana, Ni Made Adi Tarini, I Nengah Sujaya

Background and objectives: Klebsiella pneumoniae is a healthcare-associated infections agent and could be an extended spectrum β-lactamase (ESBL) producer. Understanding the transmission of this bacterium in a hospital setting needs accurate typing methods. An antibiogram is used to detect the resistance pattern of the isolates. Random Amplified Polymorphic DNA (RAPD) and Enterobacterial Repetitive Intergenic Consensus (ERIC)-PCR are rapid, technically simple, and easy-to-interpret DNA typing methods. This study aimed to evaluate the use of antibiotyping, RAPD-, and ERIC-PCR to investigate the heterogeneity of K. pneumoniae isolated from clinical specimens.

Materials and methods: The antibiograms of 46 K. pneumoniae clinical isolates were determined by Vitek® 2 Compact. All isolates underwent RAPD-PCR using AP4 primer and ERIC-PCR using ERIC-2 primer. The dendrogram was generated using the GelJ software and analyzed to determine its similarity. The analysis of antibiogram and the molecular typing diversity index was calculated using the formula of the Simpson's diversity index.

Results: About 71.7% of the isolates were ESBL-producers, and more than 80% of isolates were susceptible to amikacin, ertapenem, and meropenem. The antibiotyping produced 32 diverse types with DI = 0.964. In addition, the RAPD-PCR produced 47 different types with DI = 1, while ERIC-PCR was 46 (DI=0.999).

Conclusion: Antibiotyping, RAPD- and ERIC-PCR showed powerful discrimination power among the isolates, supported the diversity of K. pneumoniae isolates in current study. These combination could be promising tools for clonal relationship determination, including in tracking the transmission of the outbreak's agent in hospital setting.

背景和目的:肺炎克雷伯氏菌是一种医疗相关性感染病原体,可能会产生广谱β-内酰胺酶(ESBL)。了解这种细菌在医院环境中的传播情况需要准确的分型方法。抗生素图谱可用于检测分离菌的耐药性模式。随机扩增多态 DNA (RAPD) 和肠杆菌重复基因间共识 (ERIC)-PCR 是快速、技术简单且易于解释的 DNA 分型方法。本研究旨在评估抗生素鉴定、RAPD 和 ERIC-PCR 在研究从临床标本中分离的肺炎克雷伯菌异质性方面的应用:采用 Vitek® 2 Compact 测定了 46 株肺炎克雷伯菌临床分离株的抗生素图谱。使用 AP4 引物对所有分离株进行 RAPD-PCR 检测,使用 ERIC-2 引物对所有分离株进行 ERIC-PCR 检测。使用 GelJ 软件生成树枝状图并进行分析,以确定其相似性。使用辛普森多样性指数公式计算抗生素图谱和分子分型多样性指数:结果:约71.7%的分离株产ESBL,80%以上的分离株对阿米卡星、厄他培南和美罗培南敏感。抗生素鉴定产生了 32 种不同类型,DI = 0.964。此外,RAPD-PCR 产生了 47 种不同类型,DI = 1,而 ERIC-PCR 为 46 种(DI=0.999):结论:抗生素鉴定、RAPD-PCR 和 ERIC-PCR 在分离株之间显示出强大的区分能力,支持了本次研究中肺炎克雷伯菌分离株的多样性。这些组合可能成为确定克隆关系的有效工具,包括追踪疫情病原体在医院环境中的传播。
{"title":"Antibiotyping, RAPD- and ERIC-PCR fingerprinting of <i>Klebsiella pneumoniae</i> clinical isolates at a tertiary reference hospital in Denpasar, Bali, Indonesia.","authors":"Ni Nengah Dwi Fatmawati, Felicia Aviana, Ronny Maharianto, Gede Ngurah Rsi Suwardana, Ni Made Adi Tarini, I Nengah Sujaya","doi":"10.18502/ijm.v16i3.15761","DOIUrl":"10.18502/ijm.v16i3.15761","url":null,"abstract":"<p><strong>Background and objectives: </strong><i>Klebsiella pneumoniae</i> is a healthcare-associated infections agent and could be an extended spectrum β-lactamase (ESBL) producer. Understanding the transmission of this bacterium in a hospital setting needs accurate typing methods. An antibiogram is used to detect the resistance pattern of the isolates. Random Amplified Polymorphic DNA (RAPD) and Enterobacterial Repetitive Intergenic Consensus (ERIC)-PCR are rapid, technically simple, and easy-to-interpret DNA typing methods. This study aimed to evaluate the use of antibiotyping, RAPD-, and ERIC-PCR to investigate the heterogeneity of <i>K. pneumoniae</i> isolated from clinical specimens.</p><p><strong>Materials and methods: </strong>The antibiograms of 46 <i>K. pneumoniae</i> clinical isolates were determined by Vitek® 2 Compact. All isolates underwent RAPD-PCR using AP4 primer and ERIC-PCR using ERIC-2 primer. The dendrogram was generated using the GelJ software and analyzed to determine its similarity. The analysis of antibiogram and the molecular typing diversity index was calculated using the formula of the Simpson's diversity index.</p><p><strong>Results: </strong>About 71.7% of the isolates were ESBL-producers, and more than 80% of isolates were susceptible to amikacin, ertapenem, and meropenem. The antibiotyping produced 32 diverse types with DI = 0.964. In addition, the RAPD-PCR produced 47 different types with DI = 1, while ERIC-PCR was 46 (DI=0.999).</p><p><strong>Conclusion: </strong>Antibiotyping, RAPD- and ERIC-PCR showed powerful discrimination power among the isolates, supported the diversity of <i>K. pneumoniae</i> isolates in current study. These combination could be promising tools for clonal relationship determination, including in tracking the transmission of the outbreak's agent in hospital setting.</p>","PeriodicalId":14633,"journal":{"name":"Iranian Journal of Microbiology","volume":"16 3","pages":"306-313"},"PeriodicalIF":1.3,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11245350/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141616419","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Antibacterial and antibiofilm activities of zingerone and niosomal zingerone against methicillin-resistant Staphylococcus aureus (MRSA). 姜酮和姜酮气雾剂对耐甲氧西林金黄色葡萄球菌(MRSA)的抗菌和抗生物膜活性。
IF 1.3 Q4 MICROBIOLOGY Pub Date : 2024-06-01 DOI: 10.18502/ijm.v16i3.15794
Laleh Larijanian, Morvarid Shafiei, Abdollah Ghasemi Pirbalouti, Atousa Ferdousi, Mohsen Chiani

Background and objectives: Methicillin-resistant Staphylococcus aureus (MRSA) is a major cause of nosocomial and community acquired infections. Nanoparticles are considered as proper tools to overcome the therapeutic problem of antimicrobial-resistant infections because of the drug concentration increment at the desired location and protection from enzymatic degradation. The goal of this study was to evaluate the effect of the antibacterial and antibiofilm activities of zingerone and niosome containing zingerone against pre-formed biofilm of MRSA isolates.

Materials and methods: 62 MRSA isolates cultured from patients with diabetic ulcers were investigated. Niosomes were synthesized and characterized by X-ray diffraction, zeta potential and scanning electron microscopy (SEM). The size of niosomal particles measured by SEM and zetasizer.

Results: The surface charge of prepared niosomes was about -37 mV. The effect of the zingerone and noisome containing zingerone was evaluated against biofilms of MRSA isolates. Also, the antibiofilm activity of prepared niosomes on gene expression of MRSA biofilms was evaluated using Real Time PCR. Our results demonstrated that the niosome containing zingerone had a diameter of 196.1 nm and a -37.3-mV zeta potential. Zingerone removed one and three-day old biofilms of MRSA at the concentration of 1000 μg/ml, while the zingerone-laoded niosomes removed 1, 3- and 5-days old biofilms at the concentration of 250 μg/ml, 250 μg/ml, and 500 μg/ml.

Conclusion: The results indicated that niosome containing zingerone eliminated MRSA and its biofilms faster compared with free zingerone and it suggested that zingerone-encapsulated niosomes could be considered as a promising treatment against MRSA and its biofilms.

背景和目的:耐甲氧西林金黄色葡萄球菌(MRSA)是引起院内和社区感染的主要原因。纳米粒子可在所需位置增加药物浓度,并防止酶降解,因此被认为是克服抗菌素耐药性感染治疗问题的适当工具。本研究的目的是评估姜酮和含有姜酮的 Niosome 对 MRSA 分离物预先形成的生物膜的抗菌和抗生物膜活性的影响。通过 X 射线衍射、ZETA 电位和扫描电子显微镜(SEM)对合成的 Niosomes 进行了表征。用扫描电子显微镜和zeta电位仪测量了niosomal颗粒的大小:结果:制备的niosomes表面电荷约为-37 mV。评估了姜酮和含有姜酮的niosomes对MRSA分离物生物膜的作用。此外,还使用 Real Time PCR 评估了制备的 niosomes 对 MRSA 生物膜基因表达的抗生物膜活性。我们的研究结果表明,含有姜酮的niosome直径为196.1 nm,zeta电位为-37.3 mV。当辛格酮的浓度为 1000 μg/ml 时,可清除一天和三天前的 MRSA 生物膜;当辛格酮的浓度为 250 μg/ml、250 μg/ml 和 500 μg/ml 时,可清除一天、三天和五天前的生物膜:结果表明,与游离姜酮相比,含有姜酮的niosome能更快地清除MRSA及其生物膜。
{"title":"Antibacterial and antibiofilm activities of zingerone and niosomal zingerone against methicillin-resistant <i>Staphylococcus aureus</i> (MRSA).","authors":"Laleh Larijanian, Morvarid Shafiei, Abdollah Ghasemi Pirbalouti, Atousa Ferdousi, Mohsen Chiani","doi":"10.18502/ijm.v16i3.15794","DOIUrl":"10.18502/ijm.v16i3.15794","url":null,"abstract":"<p><strong>Background and objectives: </strong>Methicillin-resistant <i>Staphylococcus aureus</i> (MRSA) is a major cause of nosocomial and community acquired infections. Nanoparticles are considered as proper tools to overcome the therapeutic problem of antimicrobial-resistant infections because of the drug concentration increment at the desired location and protection from enzymatic degradation. The goal of this study was to evaluate the effect of the antibacterial and antibiofilm activities of zingerone and niosome containing zingerone against pre-formed biofilm of MRSA isolates.</p><p><strong>Materials and methods: </strong>62 MRSA isolates cultured from patients with diabetic ulcers were investigated. Niosomes were synthesized and characterized by X-ray diffraction, zeta potential and scanning electron microscopy (SEM). The size of niosomal particles measured by SEM and zetasizer.</p><p><strong>Results: </strong>The surface charge of prepared niosomes was about -37 mV. The effect of the zingerone and noisome containing zingerone was evaluated against biofilms of MRSA isolates. Also, the antibiofilm activity of prepared niosomes on gene expression of MRSA biofilms was evaluated using Real Time PCR. Our results demonstrated that the niosome containing zingerone had a diameter of 196.1 nm and a -37.3-mV zeta potential. Zingerone removed one and three-day old biofilms of MRSA at the concentration of 1000 μg/ml, while the zingerone-laoded niosomes removed 1, 3- and 5-days old biofilms at the concentration of 250 μg/ml, 250 μg/ml, and 500 μg/ml.</p><p><strong>Conclusion: </strong>The results indicated that niosome containing zingerone eliminated MRSA and its biofilms faster compared with free zingerone and it suggested that zingerone-encapsulated niosomes could be considered as a promising treatment against MRSA and its biofilms.</p>","PeriodicalId":14633,"journal":{"name":"Iranian Journal of Microbiology","volume":"16 3","pages":"366-375"},"PeriodicalIF":1.3,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11245341/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141616418","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The chimeric UreB, FliD and Omp18 proteins for a sensitive and specific diagnosis of Helicobacter pylori infections. 嵌合 UreB、FliD 和 Omp18 蛋白用于幽门螺旋杆菌感染的敏感性和特异性诊断。
IF 1.3 Q4 MICROBIOLOGY Pub Date : 2024-06-01 DOI: 10.18502/ijm.v16i3.15768
Hassan Seyyedhamzeh, Safar Farajnia, Mohammad Kargar, Behzad Baradaran, Farshid Kafilzadeh

Background and objectives: Helicobacter pylori is known as the main cause of gastrointestinal diseases including gastritis, gastric ulcer and stomach cancer. Serodiagnosis of H. pylori infection is a noninvasive and rapid method but the efficiency of this method is highly dependent to the antigens used. This study evaluated the efficacy of recombinant UreB-Omp18 and FliD for serodiagnosis of H. pylori infection.

Materials and methods: The genes encoding for fliD, ureB, and omp18 was amplified by PCR and cloned into pET-22b and pET-28a vectors. The constructs were expressed in E. coli BL21 and purified by affinity chromatography. The antigenic properties and diagnostic potential of the recombinant proteins were analysed by immunoblotting and ELISA, respectively.

Results: The recombinant UreB-Omp18 and FliD with molecular weights of 48 kDa and 25 kDa were observed on SDS-PAGE and purified by the Ni-NTA column. The ELISA results showed that the sensitivity and specificity of recombinant UreB-Omp18 protein in serodiagnosis of H. pylori infection were 89% and 83%, respectively. Also, the sensitivity and specificity of the recombinant FliD protein were calculated to be 91% and 76%, respectively.

Conclusion: The results indicated that the recombinant UreB-Omp18 and FliD could diagnose H. pylori infection with high sensitivity and specificity.

背景和目的:幽门螺杆菌是胃炎、胃溃疡和胃癌等胃肠道疾病的主要致病菌。幽门螺杆菌感染的血清诊断是一种非侵入性的快速方法,但这种方法的效率与所使用的抗原有很大关系。本研究评估了重组 UreB-Omp18 和 FliD 在幽门螺杆菌感染血清诊断中的有效性:通过 PCR 扩增 fliD、ureB 和 omp18 的编码基因,并将其克隆到 pET-22b 和 pET-28a 载体中。构建体在大肠杆菌 BL21 中表达,并通过亲和层析进行纯化。分别用免疫印迹法和酶联免疫吸附法分析了重组蛋白的抗原性和诊断潜力:结果:重组蛋白 UreB-Omp18 和 FliD 在 SDS-PAGE 上的分子量分别为 48 kDa 和 25 kDa,并经 Ni-NTA 柱纯化。ELISA 结果显示,重组 UreB-Omp18 蛋白在幽门螺杆菌感染血清诊断中的灵敏度和特异性分别为 89% 和 83%。重组 FliD 蛋白的敏感性和特异性分别为 91% 和 76%:结果表明,重组 UreB-Omp18 和 FliD 能以较高的灵敏度和特异性诊断幽门螺杆菌感染。
{"title":"The chimeric UreB, FliD and Omp18 proteins for a sensitive and specific diagnosis of <i>Helicobacter pylori</i> infections.","authors":"Hassan Seyyedhamzeh, Safar Farajnia, Mohammad Kargar, Behzad Baradaran, Farshid Kafilzadeh","doi":"10.18502/ijm.v16i3.15768","DOIUrl":"10.18502/ijm.v16i3.15768","url":null,"abstract":"<p><strong>Background and objectives: </strong><i>Helicobacter pylori</i> is known as the main cause of gastrointestinal diseases including gastritis, gastric ulcer and stomach cancer. Serodiagnosis of <i>H. pylori</i> infection is a noninvasive and rapid method but the efficiency of this method is highly dependent to the antigens used. This study evaluated the efficacy of recombinant UreB-Omp18 and FliD for serodiagnosis of <i>H. pylori</i> infection.</p><p><strong>Materials and methods: </strong>The genes encoding for <i>fliD, ureB,</i> and <i>omp18</i> was amplified by PCR and cloned into pET-22b and pET-28a vectors. The constructs were expressed in <i>E. coli</i> BL21 and purified by affinity chromatography. The antigenic properties and diagnostic potential of the recombinant proteins were analysed by immunoblotting and ELISA, respectively.</p><p><strong>Results: </strong>The recombinant UreB-Omp18 and FliD with molecular weights of 48 kDa and 25 kDa were observed on SDS-PAGE and purified by the Ni-NTA column. The ELISA results showed that the sensitivity and specificity of recombinant UreB-Omp18 protein in serodiagnosis of <i>H. pylori</i> infection were 89% and 83%, respectively. Also, the sensitivity and specificity of the recombinant FliD protein were calculated to be 91% and 76%, respectively.</p><p><strong>Conclusion: </strong>The results indicated that the recombinant UreB-Omp18 and FliD could diagnose <i>H. pylori</i> infection with high sensitivity and specificity.</p>","PeriodicalId":14633,"journal":{"name":"Iranian Journal of Microbiology","volume":"16 3","pages":"357-365"},"PeriodicalIF":1.3,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11245343/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141616464","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Concomitant tuberculosis and aspergillosis in patients with COVID-19: a case report. COVID-19 患者合并结核病和曲霉菌病:病例报告。
IF 1.3 Q4 MICROBIOLOGY Pub Date : 2024-06-01 DOI: 10.18502/ijm.v16i3.15800
Elahe Sasani, Sadegh Khodavaisy, Mohammadreza Salehi, Sareh Bagheri-Josheghani, Mahsa Abdorahimi, Seyed Ali Dehghan Manshadi, Alireza Abdollahi, Amir Salami, Marjan Sohrabi, Arezoo Salami Khaneshan

Coexisting pulmonary aspergillosis and tuberculosis in a post-COVID-19 patient is rare. Here, we are going to report a case of combined pulmonary aspergillosis and tuberculosis in a 51-year-old female who was previously diagnosed with COVID-19 pneumonia. The patient was treated with voriconazole and anti-tuberculosis agents.

COVID-19 后患者同时患有肺曲霉菌病和结核病的情况非常罕见。在此,我们将报告一例合并肺曲霉菌病和肺结核的病例,患者是一名 51 岁的女性,曾被诊断为 COVID-19 肺炎。患者接受了伏立康唑和抗结核药物治疗。
{"title":"Concomitant tuberculosis and aspergillosis in patients with COVID-19: a case report.","authors":"Elahe Sasani, Sadegh Khodavaisy, Mohammadreza Salehi, Sareh Bagheri-Josheghani, Mahsa Abdorahimi, Seyed Ali Dehghan Manshadi, Alireza Abdollahi, Amir Salami, Marjan Sohrabi, Arezoo Salami Khaneshan","doi":"10.18502/ijm.v16i3.15800","DOIUrl":"10.18502/ijm.v16i3.15800","url":null,"abstract":"<p><p>Coexisting pulmonary aspergillosis and tuberculosis in a post-COVID-19 patient is rare. Here, we are going to report a case of combined pulmonary aspergillosis and tuberculosis in a 51-year-old female who was previously diagnosed with COVID-19 pneumonia. The patient was treated with voriconazole and anti-tuberculosis agents.</p>","PeriodicalId":14633,"journal":{"name":"Iranian Journal of Microbiology","volume":"16 3","pages":"428-433"},"PeriodicalIF":1.3,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11245357/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141616422","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Designing the fusion protein of rotavirus VP8 and hepatitis A virus VP1 and evaluating the immunological response in BALB/c mice. 设计轮状病毒 VP8 和甲型肝炎病毒 VP1 的融合蛋白并评估 BALB/c 小鼠的免疫反应。
IF 1.3 Q4 MICROBIOLOGY Pub Date : 2024-06-01 DOI: 10.18502/ijm.v16i3.15797
Hassan Yarmohammadi, Mohammadreza Aghasadeghi, Abbas Akhavan Sepahi, Mojtaba Hamidi-Fard, Golnaz Bahramali

Background and objectives: Rotavirus and Hepatitis A virus are responsible for causing gastroenteritis and jaundice. The current vaccination approaches have proven insufficient, especially in low-income countries. In this study, we presented a novel dual-vaccine candidate that combines the rotavirus VP8 protein and the hepatitis A virus VP1.

Materials and methods: The VP8*-rotavirus+AAY+HAV-VP1 fusion protein was produced using an Escherichia coli expression system. The recombinant protein had a molecular weight of approximately 45.5 kDa and was purified through affinity chromatography. BALB/c mice were injected subcutaneously with the recombinant protein, VP1, VP8 and vaccines for rotavirus and hepatitis A virus, both with and without ALUM and M720 adjuvants. ELISA assays were used to measure total IgG, IgG1, IgG2, and short-term and long-term IL-5 and IFN-γ responses.

Results: The fusion protein, when combined with adjuvants, elicited significantly higher total IgG, IgG1, and IgG2 responses compared to VP1 and VP8 alone, as well as the rotavirus and hepatitis A vaccines. Furthermore, it induced a higher short-term IL-5 and IFN-γ response while demonstrating a higher long-term IL-5 response compared to the rotavirus and hepatitis A vaccines.

Conclusion: This study demonstrates that the VP8*-rotavirus+AAY+HAV-VP1 fusion protein is a promising dual vaccine candidate for immunization against hepatitis A and rotaviruses.

背景和目的:轮状病毒和甲型肝炎病毒可引起肠胃炎和黄疸。目前的疫苗接种方法已被证明是不够的,尤其是在低收入国家。在这项研究中,我们提出了一种新型双疫苗候选方案,它结合了轮状病毒 VP8 蛋白和甲型肝炎病毒 VP1:采用大肠杆菌表达系统生产出 VP8*-rotavirus+AAY+HAV-VP1 融合蛋白。重组蛋白的分子量约为 45.5 kDa,并通过亲和层析进行纯化。给 BALB/c 小鼠皮下注射重组蛋白、VP1、VP8 以及轮状病毒和甲型肝炎病毒疫苗(含或不含 ALUM 和 M720 佐剂)。采用 ELISA 方法测定总 IgG、IgG1、IgG2 以及短期和长期 IL-5 和 IFN-γ 反应:结果:与单独的 VP1 和 VP8 疫苗以及轮状病毒和甲型肝炎疫苗相比,融合蛋白与佐剂结合可引起明显更高的总 IgG、IgG1 和 IgG2 反应。此外,与轮状病毒疫苗和甲型肝炎疫苗相比,它能诱导更高的短期 IL-5 和 IFN-γ 反应,同时表现出更高的长期 IL-5 反应:本研究表明,VP8*-轮状病毒+AAY+HAV-VP1融合蛋白是一种很有前景的候选双联疫苗,可用于甲型肝炎和轮状病毒的免疫接种。
{"title":"Designing the fusion protein of rotavirus VP8 and hepatitis A virus VP1 and evaluating the immunological response in BALB/c mice.","authors":"Hassan Yarmohammadi, Mohammadreza Aghasadeghi, Abbas Akhavan Sepahi, Mojtaba Hamidi-Fard, Golnaz Bahramali","doi":"10.18502/ijm.v16i3.15797","DOIUrl":"10.18502/ijm.v16i3.15797","url":null,"abstract":"<p><strong>Background and objectives: </strong>Rotavirus and Hepatitis A virus are responsible for causing gastroenteritis and jaundice. The current vaccination approaches have proven insufficient, especially in low-income countries. In this study, we presented a novel dual-vaccine candidate that combines the rotavirus VP8 protein and the hepatitis A virus VP1.</p><p><strong>Materials and methods: </strong>The VP8*-rotavirus+AAY+HAV-VP1 fusion protein was produced using an <i>Escherichia coli</i> expression system. The recombinant protein had a molecular weight of approximately 45.5 kDa and was purified through affinity chromatography. BALB/c mice were injected subcutaneously with the recombinant protein, VP1, VP8 and vaccines for rotavirus and hepatitis A virus, both with and without ALUM and M720 adjuvants. ELISA assays were used to measure total IgG, IgG1, IgG2, and short-term and long-term IL-5 and IFN-γ responses.</p><p><strong>Results: </strong>The fusion protein, when combined with adjuvants, elicited significantly higher total IgG, IgG1, and IgG2 responses compared to VP1 and VP8 alone, as well as the rotavirus and hepatitis A vaccines. Furthermore, it induced a higher short-term IL-5 and IFN-γ response while demonstrating a higher long-term IL-5 response compared to the rotavirus and hepatitis A vaccines.</p><p><strong>Conclusion: </strong>This study demonstrates that the VP8*-rotavirus+AAY+HAV-VP1 fusion protein is a promising dual vaccine candidate for immunization against hepatitis A and rotaviruses.</p>","PeriodicalId":14633,"journal":{"name":"Iranian Journal of Microbiology","volume":"16 3","pages":"401-410"},"PeriodicalIF":1.3,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11245353/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141616423","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Epidemiological and phylogenetic assessment of human respiratory syncytial virus among pediatric patients presenting acute respiratory infections in Shiraz, Iran during 2015-2016. 2015-2016 年伊朗设拉子急性呼吸道感染儿科患者中人类呼吸道合胞病毒的流行病学和系统发育评估。
IF 1.3 Q4 MICROBIOLOGY Pub Date : 2024-06-01 DOI: 10.18502/ijm.v16i3.15798
Saber Mojarrad, Nahid Tavakoli Movaghar, Fahime Edalat, Arash Letafati, Zahra Kargar Jahromi, Afagh Moattari

Background and objectives: The pediatric population worldwide bears a significant morbidity and death burden due to acute respiratory infections (ARIs). Human Orthopneumovirus, sometimes referred to as the Human Respiratory Syncytial Virus (HRSV), is one of the main causes of ARIs in infants. The main goal of this study was to identify the genetic diversity of HRSV strains that were circulating in the Iranian population at a certain time of year.

Materials and methods: Two hundred youngsters less than 12 years old with acute respiratory infections had samples taken from their throat and pharynx secretions. Then, external and hemi-nested PCR were employed, using specific primers targeting the G gene region to detect HRSV. Subsequently, nine randomly selected positive samples were subjected to sequencing. The results were then compared with reference strains cataloged in GeneBank, and phylogenetic tree was constructed using Chromes and MEGA7.

Results: Out of 200 samples, 34 were identified as containing HRSV. Subgroup A was predominant, accounting for 61.76% of cases, followed by subgroup BA (35.29%) and subgroup B (2.94%). Phylogenetic analysis revealed five samples associated with subtype B and four with genotype A. Genomic analysis showed three samples under the GA2 subgroup and one under GA1 for subtype A, and four samples in subgroup BA and one in GB2 for subtype B.

Conclusion: In this study, subgroup A strains, particularly genotype GA2, exhibited a higher prevalence compared to subgroup B strains during the specific period under investigation, shedding light on the genetic landscape of HRSV in this region.

背景和目的:急性呼吸道感染(ARIs)给全球儿科人口带来了巨大的发病和死亡负担。人类正肺炎病毒(有时也称为人类呼吸道合胞病毒(HRSV))是导致婴儿急性呼吸道感染的主要原因之一。本研究的主要目的是确定一年中某个时期在伊朗人群中流行的 HRSV 株系的遗传多样性:从 200 名患有急性呼吸道感染的 12 岁以下青少年的喉咙和咽部分泌物中提取样本。然后,使用针对 G 基因区的特异引物进行外部和半嵌合 PCR,以检测 HRSV。随后,对随机抽取的九个阳性样本进行了测序。然后将结果与基因库中的参考菌株进行比较,并使用 Chromes 和 MEGA7 构建系统发生树:结果:在 200 份样本中,有 34 份被鉴定为含有 HRSV。A亚群占主导地位,占病例总数的61.76%,其次是BA亚群(35.29%)和B亚群(2.94%)。基因组分析显示,A亚型有3个样本属于GA2亚组,1个属于GA1亚组,B亚型有4个样本属于BA亚组,1个属于GB2亚组:在本研究中,A亚群菌株,尤其是基因型为GA2的菌株,与B亚群菌株相比,在调查的特定时期表现出更高的流行率,从而揭示了该地区HRSV的基因状况。
{"title":"Epidemiological and phylogenetic assessment of human respiratory syncytial virus among pediatric patients presenting acute respiratory infections in Shiraz, Iran during 2015-2016.","authors":"Saber Mojarrad, Nahid Tavakoli Movaghar, Fahime Edalat, Arash Letafati, Zahra Kargar Jahromi, Afagh Moattari","doi":"10.18502/ijm.v16i3.15798","DOIUrl":"10.18502/ijm.v16i3.15798","url":null,"abstract":"<p><strong>Background and objectives: </strong>The pediatric population worldwide bears a significant morbidity and death burden due to acute respiratory infections (ARIs). Human Orthopneumovirus, sometimes referred to as the Human Respiratory Syncytial Virus (HRSV), is one of the main causes of ARIs in infants. The main goal of this study was to identify the genetic diversity of HRSV strains that were circulating in the Iranian population at a certain time of year.</p><p><strong>Materials and methods: </strong>Two hundred youngsters less than 12 years old with acute respiratory infections had samples taken from their throat and pharynx secretions. Then, external and hemi-nested PCR were employed, using specific primers targeting the G gene region to detect HRSV. Subsequently, nine randomly selected positive samples were subjected to sequencing. The results were then compared with reference strains cataloged in GeneBank, and phylogenetic tree was constructed using Chromes and MEGA7.</p><p><strong>Results: </strong>Out of 200 samples, 34 were identified as containing HRSV. Subgroup A was predominant, accounting for 61.76% of cases, followed by subgroup BA (35.29%) and subgroup B (2.94%). Phylogenetic analysis revealed five samples associated with subtype B and four with genotype A. Genomic analysis showed three samples under the GA2 subgroup and one under GA1 for subtype A, and four samples in subgroup BA and one in GB2 for subtype B.</p><p><strong>Conclusion: </strong>In this study, subgroup A strains, particularly genotype GA2, exhibited a higher prevalence compared to subgroup B strains during the specific period under investigation, shedding light on the genetic landscape of HRSV in this region.</p>","PeriodicalId":14633,"journal":{"name":"Iranian Journal of Microbiology","volume":"16 3","pages":"411-420"},"PeriodicalIF":1.3,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11245347/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141616425","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Iranian Journal of Microbiology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1